Literature DB >> 27367880

IFN Deficiency in Asthma Attacks. Is Restoring Toll-like Receptor-7 Expression a New Treatment Approach in Severe Asthma?

Sebastian L Johnston1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2016        PMID： 27367880      PMCID： PMC4960633          DOI： 10.1164/rccm.201602-0223ED

Source DB:  PubMed          Journal:  Am J Respir Crit Care Med        ISSN： 1073-449X            Impact factor:   21.405


× No keyword cloud information.
  23 in total

1.  Counterregulation between the FcepsilonRI pathway and antiviral responses in human plasmacytoid dendritic cells.

Authors:  Michelle A Gill; Gagan Bajwa; Tiffany A George; Caroline C Dong; Irene I Dougherty; Nan Jiang; Vanthaya N Gan; Rebecca S Gruchalla
Journal:  J Immunol       Date:  2010-04-21       Impact factor: 5.422

2.  Deficient antiviral immune responses in childhood: distinct roles of atopy and asthma.

Authors:  Simonetta Baraldo; Marco Contoli; Erica Bazzan; Graziella Turato; Anna Padovani; Brunilda Marku; Fiorella Calabrese; Gaetano Caramori; Andrea Ballarin; Deborah Snijders; Angelo Barbato; Marina Saetta; Alberto Papi
Journal:  J Allergy Clin Immunol       Date:  2012-09-13       Impact factor: 10.793

3.  Th2 cytokines impair innate immune responses to rhinovirus in respiratory epithelial cells.

Authors:  M Contoli; K Ito; A Padovani; D Poletti; B Marku; M R Edwards; L A Stanciu; G Gnesini; A Pastore; A Spanevello; P Morelli; S L Johnston; G Caramori; A Papi
Journal:  Allergy       Date:  2015-04-24       Impact factor: 13.146

4.  Rhinovirus-induced interferon production is not deficient in well controlled asthma.

Authors:  Annemarie Sykes; Jonathan Macintyre; Michael R Edwards; Ajerico Del Rosario; Jennifer Haas; Vera Gielen; Onn Min Kon; Mark McHale; Sebastian L Johnston
Journal:  Thorax       Date:  2013-10-14       Impact factor: 9.139

5.  IL-33-dependent type 2 inflammation during rhinovirus-induced asthma exacerbations in vivo.

Authors:  David J Jackson; Heidi Makrinioti; Batika M J Rana; Betty W H Shamji; Maria-Belen Trujillo-Torralbo; Joseph Footitt; Aurica G Telcian; Alexandra Nikonova; Jie Zhu; Julia Aniscenko; Leila Gogsadze; Eteri Bakhsoliani; Stephanie Traub; Jaideep Dhariwal; James Porter; Duncan Hunt; Toby Hunt; Trevor Hunt; Luminita A Stanciu; Musa Khaitov; Nathan W Bartlett; Michael R Edwards; Onn Min Kon; Patrick Mallia; Nikolaos G Papadopoulos; Cezmi A Akdis; John Westwick; Matthew J Edwards; David J Cousins; Ross P Walton; Sebastian L Johnston
Journal:  Am J Respir Crit Care Med       Date:  2014-12-15       Impact factor: 21.405

6.  Transforming growth factor-beta promotes rhinovirus replication in bronchial epithelial cells by suppressing the innate immune response.

Authors:  Nicole Bedke; David Sammut; Ben Green; Valia Kehagia; Patrick Dennison; Gisli Jenkins; Amanda Tatler; Peter H Howarth; Stephen T Holgate; Donna E Davies
Journal:  PLoS One       Date:  2012-09-06       Impact factor: 3.240

7.  Asthmatic bronchial epithelial cells have a deficient innate immune response to infection with rhinovirus.

Authors:  Peter A B Wark; Sebastian L Johnston; Fabio Bucchieri; Robert Powell; Sarah Puddicombe; Vasile Laza-Stanca; Stephen T Holgate; Donna E Davies
Journal:  J Exp Med       Date:  2005-03-21       Impact factor: 14.307

8.  Toll-like receptor 7 governs interferon and inflammatory responses to rhinovirus and is suppressed by IL-5-induced lung eosinophilia.

Authors:  Luke Hatchwell; Adam Collison; Jason Girkin; Kristy Parsons; Junyao Li; Jie Zhang; Simon Phipps; Darryl Knight; Nathan W Bartlett; Sebastian L Johnston; Paul S Foster; Peter A B Wark; Joerg Mattes
Journal:  Thorax       Date:  2015-06-24       Impact factor: 9.139

9.  Increased nuclear suppressor of cytokine signaling 1 in asthmatic bronchial epithelium suppresses rhinovirus induction of innate interferons.

Authors:  Vera Gielen; Annemarie Sykes; Jie Zhu; Brian Chan; Jonathan Macintyre; Nicolas Regamey; Elisabeth Kieninger; Atul Gupta; Amelia Shoemark; Cara Bossley; Jane Davies; Sejal Saglani; Patrick Walker; Sandra E Nicholson; Alexander H Dalpke; Onn-Min Kon; Andrew Bush; Sebastian L Johnston; Michael R Edwards
Journal:  J Allergy Clin Immunol       Date:  2015-01-25       Impact factor: 10.793

Review 10.  EAACI position statement on asthma exacerbations and severe asthma.

Authors:  A Custovic; S L Johnston; I Pavord; M Gaga; L Fabbri; E H Bel; P Le Souëf; J Lötvall; P Demoly; C A Akdis; D Ryan; M J Mäkelä; F Martinez; J W Holloway; S Saglani; P O'Byrne; A Papi; S Sergejeva; A Magnan; S Del Giacco; O Kalayci; E Hamelmann; N G Papadopoulos
Journal:  Allergy       Date:  2013-11-06       Impact factor: 13.146
View more
  3 in total

Review 1.  Delivering macrolide antibiotics to heal a broken heart - And other inflammatory conditions.

Authors:  Vincent J Venditto; David J Feola
Journal:  Adv Drug Deliv Rev       Date:  2022-03-30       Impact factor: 17.873

2.  Repetitive aeroallergen challenges elucidate maladaptive epithelial and inflammatory traits that underpin allergic airway diseases.

Authors:  Alisha M Smith; Nathan Harper; Justin A Meunier; Anne P Branum; Fabio Jimenez; Lavanya Pandranki; Andrew Carrillo; Charles S Dela Cruz; Marcos I Restrepo; Diego J Maselli; Cynthia G Rather; Anna H Heisser; Daniel A Ramirez; Weijing He; Robert A Clark; Charles P Andrews; Scott E Evans; Jacqueline A Pugh; Nu Zhang; Grace C Lee; Alvaro G Moreira; Leopoldo N Segal; Robert M Ramirez; Robert L Jacobs; Muthu Saravanan Manoharan; Jason F Okulicz; Sunil K Ahuja
Journal:  J Allergy Clin Immunol       Date:  2021-01-23       Impact factor: 14.290

3.  Eosinophil Responses at the Airway Epithelial Barrier during the Early Phase of Influenza A Virus Infection in C57BL/6 Mice.

Authors:  Meenakshi Tiwary; Robert J Rooney; Swantje Liedmann; Kim S LeMessurier; Amali E Samarasinghe
Journal:  Cells       Date:  2021-02-27       Impact factor: 6.600
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.